US Stock MarketDetailed Quotes
ESLA Estrella Immunopharma
- 0.939
- 0.0000.00%
Trading Sep 11 15:59 ET
34.14MMarket Cap-2346P/E (TTM)
0.000High0.000Low58Volume0.920Open0.939Pre Close0.00Turnover0.00%Turnover RatioLossP/E (Static)36.38MShares20.80052wk High4.01P/B9.95MFloat Cap0.81052wk Low--Dividend TTM10.60MShs Float33.000Historical High--Div YieldTTM0.00%Amplitude0.810Historical Low0.000Avg Price1Lot Size
About Estrella Immunopharma Company
Estrella Immunopharma, Inc. operates as a pre-clinical stage biopharmaceutical company, which engages in the development of T-cell therapies with the capacity to address treatment and safety challenges for patients with blood cancers and solid tumors. The company is headquartered in Emeryville, CA.
Company Profile
SymbolESLA
Company NameEstrella Immunopharma
Listing DateSep 14, 2021
CEODr. Cheng Liu, PhD
MarketNASDAQ
Fiscal Year Ends12-31
Address5858 Horton Street,Suite 370
CityEmeryville
ProvinceCalifornia
CountryUnited States of America
Zip Code94608
Phone1-510-318-9098
Websitehttps://www.estrellabio.com
Company Executives
- Name
- Position
- Salary
- Dr. Cheng Liu, PhD
- Chief Executive Officer, President and Director
- --
- Qian Yang
- Chief Operating Officer
- --
- Jiandong Xu
- Chief Financial Officer
- --
- Hong Zhang
- Chairman of the Board
- --
- Dr. Marsha Roberts
- Independent Director
- --
- Xuejun Janelle Wu
- Independent Director
- --
- Pei Xu
- Independent Director
- --
- Fan Wu
- Independent Director
- --
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg